Hugh Johnson Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-10,183
Closed -$1.94M 95
2018
Q3
$1.94M Buy
10,183
+85
+0.8% +$15.6K 0.54% 48
2018
Q2
$1.68M Buy
10,098
+226
+2% +$36.3K 0.49% 49
2018
Q1
$1.66M Sell
9,872
-84
-0.8% -$14.1K 0.5% 50
2017
Q4
$1.63M Sell
9,956
-66
-0.7% -$11.8K 0.48% 51
2017
Q3
$2.05M Buy
10,022
+125
+1% +$29.1K 0.62% 47
2017
Q2
$2.41M Sell
9,897
-145
-1% -$34.1K 0.77% 43
2017
Q1
$2.4M Buy
10,042
+340
+4% +$79.2K 0.78% 46
2016
Q4
$2.04M Sell
9,702
-926
-9% -$192K 0.71% 48
2016
Q3
$2.45M Sell
10,628
-90
-0.8% -$22K 0.91% 43
2016
Q2
$2.48M Buy
10,718
+267
+3% +$61.6K 0.96% 40
2016
Q1
$2.8M Buy
10,451
+40
+0.4% +$11.4K 1.1% 36
2015
Q4
$3.25M Sell
10,411
-24
-0.2% -$7.14K 1.24% 32
2015
Q3
$2.84M Buy
10,435
+75
+0.7% +$23K 1.15% 34
2015
Q2
$3.14M Sell
10,360
-165
-2% -$49.2K 1.11% 36
2015
Q1
$3.13M Buy
+10,525
New +$3M 1.05% 39

Other funds holding AGN

Hugh Johnson Advisors's AGN Position: Q4 2018 in Review

Hugh Johnson Advisors sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 10,183 shares — an estimated $1.94M sold.

Hugh Johnson Advisors first reported a position in AGN in Q1 2015 and held it in 15 quarters. The position peaked at $3.25M in Q4 2015. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Hugh Johnson Advisors reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Hugh Johnson Advisors sold 10,183 Allergan plc shares in Q4 2018, an estimated $1.94M.
  • Hugh Johnson Advisors first reported a position in Allergan plc in Q1 2015 and held it in 15 quarters.
  • Hugh Johnson Advisors's Allergan plc position peaked at $3.25M in Q4 2015.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Hugh Johnson Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.